“Zero Candida’s device is the next gynecologist,” says CEO and founder Eli Ben Haroosh. “This device knows how to diagnose, treat, and transmit information to the doctor or patient in real time. In ...
Supports GLP preclinical testing and planned Q4 2026 clinical study of at least 100 womenVANCOUVER, BC, Feb. 17, 2026 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results